Research Interests
Bench to bedside studies of FDA approved Vyjuvek
From pre-clinical studies to human trials, the Marinkovich lab helped develop the first approved topical gene therapy for DEB.
Collagen VII Protein Therapy for RDEB
Stanford scientists are continuing to work on developing ways to treat RDEB using type VII collagen protein (which is the protein that doesn't work correctly in RDEB).